LD-2 disclosure · 2nd Quarter - Report
ENDO PHARMACEUTICALS INC.
Client
- Name
- ENDO PHARMACEUTICALS INC.
- Description
- Speciality healthcare solutions company.
- Location
- District of Columbia · United States of America
Registrant
- Description
- ​Government Affairs Consulting Firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesTaxation/Internal Revenue Code
Issues relating to incentives for life sciences research. Tax treatment of inverted companies. Tax issues in mergers and acquisitions of US firms.
Lobbyistsmr JOSEPH H GIBSON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
Oversight of implementation of the America Invents Act. Issues relating to patent settlements. Patent reform. Issues relating to misuse of the inter pares review process.
Lobbyistsmr JOSEPH H GIBSON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to FDA approvals of new drugs and generic drugs. Issues related to the FDA. Issues related to Opioids. Issues relating to Medicare Part D rebates. Issues relating to the labeling of generic drugs. Issues relating to CDC guidance for prescribing opioids. Issues relating to products containing high doses of acetaminophen. Issues relating to removal of FDA unapproved products from the market. Opioid abuse legislation. Issues relating to prescription drug pricing. Issues relating to the removal of Opana ER from the market. Issues relating to illegal marketing of phenobarbital. Issues related to FDA approval of adrenaline.